Statin use vs. average non-HDL cholesterol levels in Latvia
Latvia: Statin use vs. average non-HDL cholesterol levels was 3.7 in 2018. ▼ Falling
Statin use vs. average non-HDL cholesterol levels in Latvia, 1980–2018
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
Analysis
The most recent figure for statin use vs. average non-hdl cholesterol levels in Latvia is 3.7, measured in 2018. That is the lowest value across all 39 years on record.
The figure is down 7.5% over ten years.
Over the whole period, statin use vs. average non-hdl cholesterol levels in Latvia peaked at 4.5 in 1980 and was at its lowest, 3.7, in 2017.
That places Latvia 12th out of 191 countries with data for 2018, putting it in the top 10%.
The long-run direction has been consistently falling across the 39 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 4.46 | 4.4 | 4.5 | 10 |
| 1990s | 4.25 | 4.1 | 4.4 | 10 |
| 2000s | 4.03 | 3.9 | 4.1 | 10 |
| 2010s | 3.81 | 3.7 | 3.9 | 9 |
Countries ranked near Latvia
- 12 Colombia 3.7 compare
- 12 Cook Islands 3.7 compare
- 12 Costa Rica 3.7 compare
- 12 Croatia 3.7 compare
- 12 France 3.7 compare
- 12 Honduras 3.7 compare
- 12 Kuwait 3.7 compare
- 12 Lithuania 3.7 compare
- 12 Mauritius 3.7 compare
- 12 Mongolia 3.7 compare
- 12 Myanmar 3.7 compare
- 12 Panama 3.7 compare
- 12 Samoa 3.7 compare
- 12 Serbia 3.7 compare
- 12 Seychelles 3.7 compare
- 12 Solomon Islands 3.7 compare
More reference data data for Latvia
- Spring temperature anomalies 4.57 °C (2026)
- Summer temperature anomalies 1.58 °C (2026)
- Temperature anomalies by month -5.99 °C (2026)
- Universal right to vote in practice 2 (2025)
- Autumn temperature anomalies 2.33 °C (2025)
- Winter temperature anomalies 3.08 °C (2025)
- Consumer price index 162.39 2010 = 100 (2025)
- Universal right to vote 2 (2025)
- Competitive elections 1 (2025)
- Men's universal right to vote 1 (2025)
Frequently asked questions
- What is statin use vs. average non-hdl cholesterol levels in Latvia?
- Statin use vs. average non-hdl cholesterol levels in Latvia was 3.7 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
- What is the highest statin use vs. average non-hdl cholesterol levels recorded in Latvia?
- The highest recorded value was 4.5 in 1980.
- What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Latvia?
- The lowest recorded value was 3.7 in 2017.
- How does Latvia rank for statin use vs. average non-hdl cholesterol levels?
- Latvia ranks 12th out of 191 countries with data for 2018.
- Is statin use vs. average non-hdl cholesterol levels rising or falling in Latvia?
- Over the last ten years it is down 7.5%. The long-run trend across the full record is falling.
- Where does this Latvia data come from?
- The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.